Ignite Creation Date:
2025-12-24 @ 5:24 PM
Ignite Modification Date:
2026-01-01 @ 9:16 PM
Study NCT ID:
NCT01480050
Status:
COMPLETED
Last Update Posted:
2019-05-22
First Post:
2011-11-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-23
First Submit QC Date:
None
Study First Post Date:
2011-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-21
Last Update Post Date:
2019-05-22
Last Update Post Date Type:
ACTUAL